JNJ vs TLRY

Johnson & Johnson (JNJ) remains a fundamentally strong, diversified healthcare conglomerate with an impressive market capitalization. While possessing robust financials, wide economic moats, and consistent performance, its sheer size ($579.46B) fundamentally misaligns with the criteria for 10x growth within a 3-5 year timeframe. A 10x return would necessitate a market cap exceeding $5.7 trillion, ...

Tilray Brands Inc. maintains its strategic positioning in the evolving global cannabis and diversified CPG markets. While recent operational results continue to show incremental improvements, including sustained positive adjusted EBITDA and progress in narrowing GAAP losses, the path to consistent profitability remains challenging. The company's significant exposure to potential US federal cannabi...